Rima A Mohammad
Overview
Explore the profile of Rima A Mohammad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
300
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
McConachie S, Hanni C, Raub J, Mohammad R, Wilhelm S
Ann Pharmacother
. 2020 Jun;
55(1):25-35.
PMID: 32578433
Background: Numerous equations are used for estimation of renal function, and many electronic medical records report multiple clearance estimates to assist with drug dosing. It is unknown whether the presence...
12.
Kosinski S, Mohammad R, Pitcher M, Haezebrouck E, Coe A, Costa D, et al.
Am J Respir Crit Care Med
. 2020 Apr;
201(8):P15-P16.
PMID: 32293204
No abstract available.
13.
Coe A, Bookstaver R, Fritschle A, Kenes M, MacTavish P, Mohammad R, et al.
Hosp Pharm
. 2020 Mar;
55(2):119-125.
PMID: 32214446
Complex medication regimen changes burden intensive care unit (ICU) survivors and their caregivers during the transition to home. Intensive care unit recovery clinics are a prime setting for pharmacists to...
14.
DiPaula B, Mohammad R, Ayers P, Basalyga V, Burton A, Bush C, et al.
Curr Pharm Teach Learn
. 2017 Dec;
10(1):21-27.
PMID: 29248070
Introduction: Developing pharmacy residents into effective preceptors is essential to meet the demands of pharmacy education. A survey was created to assess the availability of resident precepting educational opportunities, identify...
15.
Deming P, Martin M, Chan J, Dilworth T, El-Lababidi R, Love B, et al.
Pharmacotherapy
. 2016 Feb;
36(2):203-17.
PMID: 26846728
Hepatitis C virus (HCV) is the most common blood-borne infection in the United States. The high morbidity and mortality due to untreated infection have prompted updated screening recommendations that now...
16.
Smith M, Regal R, Mohammad R
Ann Pharmacother
. 2015 Oct;
50(1):39-46.
PMID: 26486762
Objectives: To review the pharmacology, efficacy, and safety of daclatasvir in the treatment of patients with chronic hepatitis C virus (HCV) infection. Data Sources: A literature search through EMBASE and...
17.
Smith M, Love B, Mohammad R
Expert Opin Drug Saf
. 2015 Sep;
14(11):1649-52.
PMID: 26365685
Treatment of chronic hepatitis C virus (HCV) therapy has rapidly changed since the approval of IFN in the 1990s. Early treatment brought about significant and therapy limiting adverse drug events...
18.
Smith M, Mohammad R
Lancet Infect Dis
. 2015 Jul;
15(9):993-995.
PMID: 26187029
No abstract available.
19.
Smith M, Chan J, Mohammad R
Ann Pharmacother
. 2014 Dec;
49(3):343-50.
PMID: 25515863
Objectives: To review the pharmacology, efficacy, and safety of ledipasvir-sofosbuvir for the treatment of chronic hepatitis C virus (HCV). Data Sources: A literature search through clinicaltrials.gov, EMBASE, and PubMed was...
20.
Mohammad R, Bulloch M, Chan J, Deming P, Love B, Smith L, et al.
Pharmacotherapy
. 2014 Nov;
34(12):1341-54.
PMID: 25359244
The objective of this opinion paper was to identify and describe potential clinical pharmacists' services for the prevention and management of patients infected with the hepatitis C virus (HCV). The...